Correlation Between Syndax Pharmaceuticals and Bolt Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Syndax Pharmaceuticals and Bolt Biotherapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Bolt Biotherapeutics.

Diversification Opportunities for Syndax Pharmaceuticals and Bolt Biotherapeutics

0.31

Correlation Coefficient

Syndax Pharmaceuticals  Bolt Biotherapeutics

Weak diversification

The 3 months correlation between Syndax and Bolt is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Bolt Biotherapeutics go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Bolt Biotherapeutics

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.96 times more return on investment than Bolt Biotherapeutics. However, Syndax Pharmaceuticals is 1.04 times less risky than Bolt Biotherapeutics. It trades about 0.16 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.04 per unit of risk. If you would invest  1,417  in Syndax Pharmaceuticals on December 2, 2024 and sell it today you would earn a total of  147.00  from holding Syndax Pharmaceuticals or generate 10.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Syndax Pharmaceuticals  vs.  Bolt Biotherapeutics

Syndax Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Syndax Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Bolt Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bolt Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Syndax Pharmaceuticals and Bolt Biotherapeutics

The main advantage of trading using opposite Syndax Pharmaceuticals and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.

The idea behind Syndax Pharmaceuticals and Bolt Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.